Home
Conditions
Hepatitis C

Clinical trial condition

Hepatitis C

Explore clinical trials studying Hepatitis C. Study availability and eligibility vary by location and protocol.

1,296 public trials 40 recruiting studies

Refine in advanced search Browse all conditions

Hepatitis C trial results

Completed

Ribavirin, Its Dosing Regime

NCT00484328

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: University of Maastricht Maastricht, Netherlands

View Trial Details

Completed

A Study to Evaluate the Safety and Efficacy of the Combined Single Dose of Dactavira Plus Or Dactavira in Egyptian Adults With Chronic Genotype 4 HCV Infection

NCT03186313

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: Egyptian Liver Hospital Sherbin, Dakahlia Governorate, Egypt

View Trial Details

Completed

A Study of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Sofosbuvir and Ribavirin in Direct-Acting Antiviral Agent Treatment-Experienced Adults With Chronic Hepatitis C Virus Infection

NCT02356562

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C Infection, +15 more
Locations: Not specified

View Trial Details

Completed

Feasibility, Tolerance and Efficacy of Interferon-free, Antiviral Treatment With Sofosbuvir + Ribavirin for the Treatment of Genotype 2 and Sofosbuvir/Ledipasvir for the Treatment of Genotype 1 and 4 Hepatitis C Virus-infected Patients in West and Central Africa

NCT02405013

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +18 more
Locations: Clinique de la Cathédrale Yaoundé, Cameroon

Centre de suivi des donneurs de sang Abidjan, Côte d’Ivoire

CHU de Youpougon - Service de Gastro-entéro-hépatologie Abidjan, Côte d’Ivoire

CHU Fann, Service des Maladies Infectieuses Dakar, Senegal

View Trial Details

Completed

Generic VEL/SOF With or Without RBV for HIV/HCV Coinfected Patients

NCT03250910

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +21 more
Locations: National Taiwan University Hospital, Yun-Lin Branch Douliu, Taiwan

National Taiwan University Hospital Taipei, Taiwan

View Trial Details

Completed

Pilot Study of HIV and Hepatitis B and C Screening in Surgery

NCT03088995

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +20 more
Locations: Yasmine Dudoit Paris, France

View Trial Details

Completed

A Follow up Study Designed to Obtain Long Term Data on Participants Who Either Achieved a Sustained Virologic Response or Did Not Achieve a Sustained Virologic Response in an AbbVie Sponsored Hepatitis C Study

NCT01773070

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Not specified

View Trial Details

Completed

Ombitasvir/Paritaprevir/Ritonavir With or Without Dasabuvir in Adults With Genotype 1a or Genotype 4 Chronic Hepatitis C Virus (HCV) Infection, With Severe Kidney Impairment or End Stage Kidney Disease

NCT02487199

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +21 more
Locations: Not specified

View Trial Details

Completed

Study of ABT-333 in Both Healthy Volunteers and Hepatitis C Virus (HCV) + Genotype 1 Infected Subjects

NCT00696904

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations: Not specified

View Trial Details

Completed

Safety, Tolerability and PK Study of Single Doses of ABT-450 With and Without Ritonavir to Treat Hepatitis C Virus (HCV) Genotype 1

NCT00850044

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations: Site Reference ID/Investigator# 15981 Waukegan, Illinois, United States

View Trial Details

Hepatitis C

Hepatitis C trial results

Related conditions